Recent insider trading activity from Schadel Christopher Ryan, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 27, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Schadel Christopher Ryan | Chief Marketing Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 4,745,089 | 9999.99% | 2.11% |
| April 27, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Schadel Christopher Ryan | Chief Marketing Officer | A | Restricted Stock Units | 9868 | $0.00 | 9,868.0000 | 4,745,089 | 9999.99% | 0.21% |